We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Tiny Robots Made Out Of Carbon Could Conduct Colonoscopy, Pelvic Exam or Blood Test

By HospiMedica International staff writers
Posted on 17 May 2024

Researchers at the University of Alberta (Edmonton, AB, Canada) are developing cutting-edge robots so tiny that they are invisible to the naked eye but are capable of traveling through the human body to remove blood clots in the brain. More...

These tiny robots, or "actuators," are designed to swim through the bloodstream to target and destroy tumors, disintegrating harmlessly after their task is accomplished.

These microrobots are engineered to detect a specific chemical emitted by a brain tumor and navigate toward it to encapsulate the tumor and halt its growth. To make this possible, a collaborative effort between engineers and medical experts at the University of Alberta is underway to develop biocompatible materials. The team has successfully demonstrated the construction of such actuators using carbon nanotubes. These nanotubes, each only five nanometres thick—10,000 times thinner than a strand of human hair—are placed on a silicon wafer. The entire assembly can measure as little as five microns, which is about one-twentieth the diameter of a human hair. These actuators are activated by an electric charge that causes them to move in specific ways, such as bending or opening and closing, to perform precise tasks.

For instance, sending an electric signal triggers an electrochemical reaction at the surface of the micro-actuator, causing it to swell—a mechanism used to open and close its end. Although still in the early stages of development, this technology might enable the micro-actuator to bend and eventually walk or swim. In the future, these microrobots could be used non-invasively for medical procedures like colonoscopies, pelvic exams, or blood tests. Additionally, the team is investigating the integration of nano-scale computer chips into these actuators and is also developing tiny batteries that provide just enough power for a single task.

“If they had processors onboard, that would be a game changer,” said Mahdi Hamidi, a professor in the Department of Mechanical Engineering at the University of Alberta who is working on the next-generation robots. “The microrobot could be connected to the internet, and you could perhaps change the program during its mission.”

Related Links:
University of Alberta


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Antimicrobial Mat
MULTIMAT
New
High Pressure Balloon Catheter
UroMax Ultra
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.